Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mice, Inbred SENCAR | 4 | 2001 | 15 | 0.280 |
Why?
|
| Housing, Animal | 2 | 2000 | 41 | 0.210 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2001 | 206 | 0.180 |
Why?
|
| Animal Welfare | 1 | 2000 | 40 | 0.180 |
Why?
|
| Animals, Laboratory | 1 | 2000 | 47 | 0.180 |
Why?
|
| Thymus Gland | 3 | 2007 | 309 | 0.130 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 5 | 2001 | 128 | 0.120 |
Why?
|
| Liver | 3 | 2012 | 3063 | 0.120 |
Why?
|
| Oxyuriasis | 1 | 1993 | 1 | 0.110 |
Why?
|
| Oxyuroidea | 1 | 1993 | 1 | 0.110 |
Why?
|
| Rats, Inbred ACI | 1 | 1993 | 11 | 0.110 |
Why?
|
| Fenbendazole | 1 | 1993 | 7 | 0.110 |
Why?
|
| Endoscopes | 1 | 2012 | 41 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2013 | 242 | 0.100 |
Why?
|
| Azoxymethane | 1 | 1991 | 44 | 0.100 |
Why?
|
| Swine, Miniature | 1 | 1991 | 71 | 0.100 |
Why?
|
| Transgenes | 2 | 2007 | 568 | 0.100 |
Why?
|
| Microscopy | 1 | 2012 | 189 | 0.090 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2012 | 166 | 0.090 |
Why?
|
| Listeriosis | 2 | 1988 | 43 | 0.090 |
Why?
|
| Collodion | 1 | 1990 | 17 | 0.090 |
Why?
|
| Immune Tolerance | 2 | 2007 | 433 | 0.090 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1991 | 200 | 0.090 |
Why?
|
| Cyclin D1 | 4 | 2000 | 591 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2013 | 1355 | 0.080 |
Why?
|
| Zinc | 2 | 1988 | 194 | 0.080 |
Why?
|
| Carcinoma | 1 | 2001 | 2610 | 0.080 |
Why?
|
| Papilloma | 2 | 2000 | 86 | 0.080 |
Why?
|
| Skin Neoplasms | 4 | 2000 | 4900 | 0.080 |
Why?
|
| Microsatellite Repeats | 2 | 2001 | 627 | 0.080 |
Why?
|
| Rodent Diseases | 2 | 2002 | 31 | 0.080 |
Why?
|
| Animals | 24 | 2013 | 61554 | 0.080 |
Why?
|
| Pancreas | 1 | 2012 | 739 | 0.080 |
Why?
|
| Immunization | 1 | 1990 | 393 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 841 | 0.080 |
Why?
|
| Cricetinae | 3 | 2007 | 762 | 0.080 |
Why?
|
| Protein Deficiency | 1 | 1988 | 20 | 0.080 |
Why?
|
| Colonic Neoplasms | 2 | 2013 | 1437 | 0.070 |
Why?
|
| Bacterial Vaccines | 1 | 1988 | 118 | 0.070 |
Why?
|
| Deoxycytidine | 1 | 2013 | 1389 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2013 | 1958 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 2000 | 248 | 0.070 |
Why?
|
| Surface Plasmon Resonance | 1 | 2007 | 97 | 0.070 |
Why?
|
| Keratin-5 | 1 | 2007 | 57 | 0.070 |
Why?
|
| Hemorrhage | 1 | 1991 | 726 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2013 | 1347 | 0.070 |
Why?
|
| Rodentia | 2 | 2000 | 71 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2007 | 1877 | 0.070 |
Why?
|
| Cheek | 2 | 2007 | 56 | 0.060 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 247 | 0.060 |
Why?
|
| Gold | 1 | 2007 | 267 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 660 | 0.060 |
Why?
|
| Hyaluronan Receptors | 1 | 2006 | 247 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 768 | 0.060 |
Why?
|
| Epithelium | 2 | 2007 | 786 | 0.050 |
Why?
|
| Quality Control | 2 | 2001 | 461 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2007 | 584 | 0.050 |
Why?
|
| Bulbourethral Glands | 1 | 2002 | 8 | 0.050 |
Why?
|
| Lung Diseases | 1 | 1988 | 751 | 0.050 |
Why?
|
| Genital Diseases, Male | 1 | 2002 | 30 | 0.050 |
Why?
|
| ErbB Receptors | 2 | 2007 | 2375 | 0.050 |
Why?
|
| Stem Cells | 2 | 2006 | 1213 | 0.050 |
Why?
|
| Perineum | 1 | 2002 | 118 | 0.050 |
Why?
|
| Wood | 1 | 2000 | 18 | 0.050 |
Why?
|
| Hygiene | 1 | 2000 | 29 | 0.040 |
Why?
|
| Zea mays | 1 | 2000 | 51 | 0.040 |
Why?
|
| Cysts | 1 | 2002 | 206 | 0.040 |
Why?
|
| Ammonia | 1 | 2000 | 85 | 0.040 |
Why?
|
| Edema | 1 | 2002 | 263 | 0.040 |
Why?
|
| Transplantation, Heterologous | 2 | 2006 | 1053 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2000 | 310 | 0.040 |
Why?
|
| Mice | 12 | 2013 | 35477 | 0.040 |
Why?
|
| CD3 Complex | 1 | 2000 | 320 | 0.040 |
Why?
|
| Swine | 2 | 2012 | 1526 | 0.040 |
Why?
|
| Hypersensitivity, Delayed | 2 | 1988 | 107 | 0.030 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1996 | 21 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 1996 | 109 | 0.030 |
Why?
|
| Species Specificity | 2 | 2000 | 790 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 5317 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 2006 | 5867 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2001 | 1557 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 4826 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 5263 | 0.030 |
Why?
|
| Rats, Mutant Strains | 1 | 1994 | 22 | 0.030 |
Why?
|
| Tail | 1 | 1994 | 29 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 14873 | 0.030 |
Why?
|
| Antigens, Neoplasm | 2 | 1991 | 1581 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 4104 | 0.030 |
Why?
|
| Immunity, Innate | 2 | 1988 | 697 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2013 | 5759 | 0.030 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1994 | 199 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2000 | 2163 | 0.020 |
Why?
|
| Learning Curve | 1 | 2012 | 79 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 506 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 5056 | 0.020 |
Why?
|
| Skin | 1 | 1997 | 1283 | 0.020 |
Why?
|
| Neoplasm Proteins | 2 | 2007 | 3345 | 0.020 |
Why?
|
| Hemangiosarcoma | 1 | 1994 | 238 | 0.020 |
Why?
|
| Neoplasms | 2 | 2007 | 15933 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 1991 | 170 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 1991 | 174 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1990 | 105 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2013 | 4331 | 0.020 |
Why?
|
| Necrosis | 1 | 1991 | 593 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 1699 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2007 | 10714 | 0.020 |
Why?
|
| Male | 10 | 2012 | 128484 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 597 | 0.020 |
Why?
|
| Time Factors | 2 | 2001 | 12991 | 0.020 |
Why?
|
| Algorithms | 1 | 2001 | 3904 | 0.020 |
Why?
|
| Rats | 3 | 1994 | 6404 | 0.020 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 1990 | 109 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2002 | 556 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 1990 | 273 | 0.020 |
Why?
|
| Rabbits | 1 | 1990 | 1045 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1990 | 888 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1990 | 293 | 0.020 |
Why?
|
| Integrin alpha6beta4 | 2 | 1998 | 32 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1988 | 251 | 0.020 |
Why?
|
| Keratins | 2 | 2000 | 340 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1991 | 589 | 0.020 |
Why?
|
| Genetic Markers | 2 | 2001 | 1073 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 1991 | 367 | 0.020 |
Why?
|
| Molecular Probe Techniques | 1 | 2007 | 46 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2000 | 3953 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2007 | 116 | 0.020 |
Why?
|
| Female | 9 | 2013 | 149120 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2006 | 1552 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1998 | 304 | 0.020 |
Why?
|
| Mouth | 1 | 2007 | 125 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2012 | 2364 | 0.020 |
Why?
|
| Carcinogens | 2 | 1998 | 390 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1991 | 705 | 0.020 |
Why?
|
| Integrins | 2 | 1998 | 274 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 2853 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 1988 | 371 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1988 | 350 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2007 | 4105 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3924 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 5594 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1986 | 437 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2002 | 4202 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1994 | 450 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2007 | 1105 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 3042 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 3204 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1991 | 7320 | 0.010 |
Why?
|
| Connexin 26 | 1 | 1997 | 22 | 0.010 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 1997 | 19 | 0.010 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1997 | 55 | 0.010 |
Why?
|
| Humans | 6 | 2013 | 271093 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1997 | 94 | 0.010 |
Why?
|
| Connexins | 1 | 1997 | 76 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1998 | 198 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 5692 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2000 | 699 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 1996 | 127 | 0.010 |
Why?
|
| Cyclins | 1 | 1997 | 465 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 439 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 367 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 548 | 0.010 |
Why?
|
| Androgens | 1 | 1998 | 506 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 3472 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1996 | 713 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 659 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2000 | 1135 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 2657 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 7232 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 3045 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1996 | 1825 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1998 | 1104 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 1993 | 33808 | 0.010 |
Why?
|
| Genotype | 1 | 2000 | 4249 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 1991 | 52 | 0.010 |
Why?
|
| Methylnitrosourea | 1 | 1991 | 51 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 16720 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1991 | 185 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2000 | 7054 | 0.000 |
Why?
|
| Germ-Line Mutation | 1 | 1994 | 1101 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1998 | 6343 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 5775 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1998 | 7645 | 0.000 |
Why?
|
| Listeria monocytogenes | 1 | 1986 | 61 | 0.000 |
Why?
|
| Middle Aged | 1 | 2012 | 90524 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1991 | 3330 | 0.000 |
Why?
|
| DNA Replication | 1 | 1986 | 768 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 1719 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1986 | 1273 | 0.000 |
Why?
|
| Vaccination | 1 | 1986 | 1148 | 0.000 |
Why?
|
| Diet | 1 | 1986 | 1473 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1991 | 9044 | 0.000 |
Why?
|